Xylazine ("Tranq") in Philadelphia: What You Need to Know

Back to resources

If you live in Philadelphia and have any connection to the opioid crisis — as someone who uses drugs, a family member, or a provider — you have almost certainly heard the word "tranq." It refers to xylazine, a veterinary sedative that has quietly become one of the most dangerous additives in the city's street drug supply.

Philadelphia is, unfortunately, the national epicenter of xylazine. Understanding what it is — and what it isn't — can genuinely save a life.

90%+
of street opioid samples tested in Philadelphia have been found to contain xylazine
2023
the year the U.S. government designated fentanyl mixed with xylazine an "emerging threat"
0
approved human uses — xylazine is licensed only as an animal sedative

What is xylazine?

Xylazine is a sedative, muscle relaxant, and pain reliever approved for use in animals — most commonly horses and cattle. It is not approved for use in humans. On the street it's known as "tranq," and drugs cut with it are often called "tranq dope."

It's mixed into fentanyl for a few reasons: it's cheap, it extends and deepens fentanyl's sedating effect, and it's not currently a federally controlled substance in the way opioids are. For the person using, the result is a longer, heavier sedation — and a dramatically higher set of risks.

If you suspect an overdose, call 911 immediately and give naloxone (Narcan). Then stay with the person, and place them in the recovery position if they're breathing. Never assume someone is "just sleeping it off."

Why naloxone still matters — even though it doesn't reverse xylazine

This is the single most important thing to understand about tranq. Xylazine is not an opioid. It's an alpha-2 agonist, a different class of drug entirely. That means naloxone (Narcan) does not reverse the effects of xylazine itself.

But here's why you should always give naloxone anyway: xylazine in Philadelphia almost never appears alone. It's mixed with fentanyl — and naloxone absolutely does reverse the fentanyl, which is the part most likely to stop someone's breathing. Reversing the opioid can restore breathing even if the person remains sedated from the xylazine.

So the response to a suspected tranq overdose is the same lifesaving sequence:

"Narcan won't undo the tranq — but it can still bring back someone's breathing. Always give it. Always call 911."

The wounds: why tranq is different

One of the most visible and devastating effects of xylazine is severe skin wounds. These are not ordinary injection marks. Xylazine restricts blood flow, and over time it can cause deep, slow-healing ulcers that may appear anywhere on the body — not just where a person injects, and even in people who don't inject at all.

Left untreated, these wounds can become infected, lead to serious complications, and in the worst cases result in amputation. The shame and fear surrounding them often keep people from seeking medical care until the damage is advanced.

If you or someone you love has these wounds, please know: wound care is available, treatable, and nothing to be ashamed of. Many Philadelphia health centers and harm-reduction programs offer wound care with no judgment, and early treatment makes an enormous difference.

Withdrawal from tranq is harder — and standard opioid protocols aren't enough

Because xylazine is not an opioid, the medications used to ease opioid withdrawal — like buprenorphine (Suboxone) or methadone — treat the fentanyl dependence but do not fully address the xylazine component. People withdrawing from tranq dope frequently report intense anxiety, agitation, restlessness, and physical discomfort that standard opioid withdrawal management doesn't resolve.

This is exactly why medically supervised detox matters so much with tranq. Trying to stop on your own is not only miserable — it can be genuinely unsafe. A medical team can manage both the opioid and the xylazine sides of withdrawal, keeping you comfortable and stable enough to actually make it through.

If you're trying to stop using tranq dope, you don't have to white-knuckle it alone. Reach out to Philadelphia Recovery Solutions and we'll help you find the right starting point — including a referral to medical detox if that's what you need first.

What treatment looks like

Recovery from tranq dope is possible, and thousands of Philadelphians are living proof. Because xylazine sits on top of a fentanyl addiction, effective treatment usually addresses several things at once:

At Philadelphia Recovery Solutions, we provide the outpatient piece of this picture — intensive outpatient (IOP) and partial hospitalization (PHP) — and we coordinate directly with detox and medical providers so the handoff is seamless. If you're not sure where to start, that's exactly the kind of question our team answers every day.

For families and providers

If you're a family member, the most important thing to know is that the presence of tranq doesn't make recovery impossible — it makes the right kind of care more important. Ask any program you're considering whether they understand xylazine, how they coordinate detox and wound care, and how they handle the prolonged withdrawal.

If you're a provider or social worker, we accept referrals directly from detox facilities, emergency departments, and behavioral health partners, and we keep clinical communication open with your team throughout treatment.

Philadelphia Recovery Solutions offers outpatient IOP and PHP treatment for opioid and tranq-involved substance use at our South Philadelphia location, with coordinated referrals for detox and wound care. Same-week intake available. Contact us today or call (215) 770-1694.

In crisis right now? Call or text 988 for the Suicide & Crisis Lifeline, or call 911 for an emergency. You can also reach Philadelphia's 24/7 behavioral health crisis line through the city's Department of Behavioral Health.

Sources & further reading:
Philadelphia Department of Public Health. Substance Use Data Dashboards & xylazine surveillance reports. phila.gov — U.S. Office of National Drug Control Policy (2023). Fentanyl Adulterated or Associated with Xylazine designated an Emerging Threat. — U.S. Food & Drug Administration. FDA alerts health care professionals of risks to patients exposed to xylazine. fda.gov — National Institute on Drug Abuse. Xylazine. nida.nih.gov